Description: XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
Home Page: www.xbiotech.com
5217 Winnebago Lane
Austin,
TX
78744
United States
Phone:
512 386 2900
Officers
| Name | Title |
|---|---|
| Mr. John Simard | Founder, President, CEO & Chairman |
| Ms. Angela Hu | Director of Finance |
| Dr. Sushma Shivaswamy Ph.D. | Chief Scientific Officer |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.9826 |
| Price-to-Sales TTM: | 12.6666 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 82 |